Position in NUVB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,527,468
-$14,815,305 QoQ
Shares Held
3,153,256
-0.3% QoQ
Ownership
0.906%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Redmile Group, LLC holds $1,432,283,191 across 31 Biotechnology names. NUVB ranks #18 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
9,066,621 | $445,715,088 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
673,505 | $173,979,811 | |
| 3 | STOK |
Stoke Therapeutics, Inc.
|
4,164,120 | $135,583,747 | |
| 4 | IMNM |
Immunome Inc.
|
5,558,885 | $121,572,814 | |
| 5 | NRIX |
Nurix Therapeutics, Inc.
|
7,732,808 | $119,858,524 | |
| 6 | ANNX |
Annexon, Inc.
|
14,549,768 | $80,605,714 | |
| 7 | RGNX |
REGENXBIO Inc.
|
4,368,804 | $36,610,577 | |
| 8 | STTK |
Shattuck Labs, Inc.
|
5,539,724 | $35,620,425 |
All Filings in NUVB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,527,468 | 3,153,256 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $28,342,773 | 3,163,256 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,214,733 | 3,031,009 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,910,467 | 3,031,009 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,334,575 | 3,031,009 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,062,483 | 3,031,009 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,941,010 | 3,031,009 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,850,546 | 3,031,009 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,032,872 | 3,031,009 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,576,823 | 3,031,009 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,061,552 | 3,031,009 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,455,816 | 3,031,009 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,031,474 | 3,031,009 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,819,537 | 3,031,009 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,789,460 | 3,031,009 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,248,337 | 3,471,709 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $18,261,189 | 3,471,709 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $31,203,576 | 3,671,009 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $45,137,629 | 4,541,009 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $42,276,793 | 4,541,009 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $47,453,544 | 4,541,009 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||